Concordia Healthcare Corp. (NASDAQ:CXRX)’s share price was down 2.8% during mid-day trading on Thursday . The stock traded as low as $16.25 and last traded at $16.54, with a volume of 474,279 shares trading hands. The stock had previously closed at $17.01.

Several equities analysts recently issued reports on CXRX shares. Zacks Investment Research raised shares of Concordia Healthcare Corp. from a “sell” rating to a “hold” rating in a report on Monday, April 25th. TD Securities reissued a “buy” rating and set a $37.00 price objective (down from $45.00) on shares of Concordia Healthcare Corp. in a report on Wednesday, June 29th. Canaccord Genuity reissued a “buy” rating on shares of Concordia Healthcare Corp. in a report on Saturday, April 23rd. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $73.00 price objective on shares of Concordia Healthcare Corp. in a report on Thursday, May 26th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $48.88.

The company’s market cap is $516.79 million. The firm’s 50 day moving average price is $18.83 and its 200 day moving average price is $25.49.

Concordia Healthcare Corp. (NASDAQ:CXRX) last issued its quarterly earnings data on Friday, August 12th. The company reported $1.38 EPS for the quarter, hitting the consensus estimate of $1.38. The company earned $231.70 million during the quarter, compared to analyst estimates of $229.76 million. The business’s quarterly revenue was up 208.1% on a year-over-year basis. On average, equities research analysts predict that Concordia Healthcare Corp. will post $5.80 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 29th. Stockholders of record on Friday, July 15th were issued a $0.075 dividend. The ex-dividend date of this dividend was Wednesday, July 13th. This represents a $0.30 annualized dividend and a dividend yield of 2.96%.

An institutional investor recently raised its position in Concordia Healthcare Corp. stock. Swiss National Bank raised its position in Concordia Healthcare Corp. (NASDAQ:CXRX) by 26.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,810 shares of the company’s stock after buying an additional 10,510 shares during the period. Swiss National Bank owned approximately 0.10% of Concordia Healthcare Corp. worth $2,031,000 at the end of the most recent quarter.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.